A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PRRT

Search Conditions:
Search Keyword : PRRT
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: PRRT
Appearance Frequency: 808 time(s)
Long forms: 26

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
peptide receptor radionuclide therapy
(760 times)
Nuclear Medicine
(298 times)
NETs (159 times)
NET (99 times)
PFS (83 times)
1998 D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
peptide radionuclide receptor therapy
(9 times)
Neoplasms
(4 times)
NET (2 times)
SSTR (2 times)
BN (1 time)
2010 A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.
peptide radioreceptor therapy
(9 times)
General Surgery
(3 times)
NET (3 times)
SSTR (3 times)
NEN (2 times)
2009 [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].
Primal Reflex Release Technique
(3 times)
BPDs (1 time)
DPA (1 time)
PF (1 time)
2015 A NOVEL APPROACH TO TREATING PLANTAR FASCIITIS - EFFECTS OF PRIMAL REFLEX RELEASE TECHNIQUE: A CASE SERIES.
pseudorandom rotation test
(3 times)
Otolaryngology
(2 times)
SHAT (3 times)
VST (3 times)
ICC (1 time)
2007 Evaluation of the rotatory vestibular test: exploration of stimulus parameters.
preoperative radiotherapy
(2 times)
Medicine
(1 time)
PORT (2 times)
SEER (2 times)
DSS (1 time)
2018 Trends and outcomes of neoadjuvant radiotherapy compared with postoperative radiotherapy for malignant breast cancer.
proline-rich transmembrane protein
(2 times)
Pharmacology
(1 time)
AMPA (1 time)
Syts (1 time)
2016 PRRT2: from Paroxysmal Disorders to Regulation of Synaptic Function.
protease, reverse-transcriptase
(2 times)
CRFs (1 time)
DB (1 time)
DBS (1 time)
2022 A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
nanoparticle-mediated-peptide receptor radionuclide therapy
(1 time)
Nuclear Medicine
(1 time)
SSR (1 time)
2016 Evaluation of cytotoxic and tumor targeting capability of (177)Lu-DOTATATE-nanoparticles: a trailblazing strategy in peptide receptor radionuclide therapy.
10  Parallel RRT
(1 time)
--- 2015 Scalable Multicore Motion Planning Using Lock-Free Concurrency.
11  pathogens resistant to recommended treatment
(1 time)
Communicable Diseases
(1 time)
DFI (1 time)
MDROs (1 time)
MRSA (1 time)
2018 Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial Therapy.
12  patients for radiolabelled peptide therapy
(1 time)
NETs (1 time)
2021 Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE.
13  patients receiving receptor mediated radionuclide therapy
(1 time)
Nuclear Medicine
(1 time)
MR (1 time)
NET (1 time)
PD (1 time)
2010 Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients.
14  patients who may benefit from radionuclide therapy
(1 time)
Neoplasms
(1 time)
NEN (1 time)
2022 New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms.
15  pave the way for apeptide receptor radionuclide therapy
(1 time)
Radiology
(1 time)
CT (1 time)
MRI (1 time)
PET (1 time)
2020 [Theranostics and hybrid imaging for somatostatin receptor-expressing tumors].
16  peptide radionuclide therapy
(1 time)
Neoplasms
(1 time)
5-aza-dC (1 time)
DNMTi (1 time)
HDACi (1 time)
2022 Epigenetic-Like Stimulation of Receptor Expression in SSTR2 Transfected HEK293 Cells as a New Therapeutic Strategy.
17  peptide receptor radionuclide
(1 time)
Nuclear Medicine
(1 time)
--- 2015 Complete Remission of Metastatic Neuroendocrine Paragastric Carcinoma After "Neoadjuvant" Peptide Receptor Radionuclide Therapy and Surgery.
18  peptide receptor radiopharmaceutical therapy
(1 time)
Nuclear Medicine
(1 time)
GEP (1 time)
NETs (1 time)
SSTR (1 time)
2022 Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs.
19  peptide receptor-mediated radiotherapy
(1 time)
Neoplasms
(1 time)
GISTs (1 time)
SSTR (1 time)
T/B (1 time)
2012 Gastrointestinal stromal tumors (GISTs) express somatostatin receptors and bind radiolabeled somatostatin analogs.
20  Peptide-radio-receptor treatment
(1 time)
Antineoplastic Agents
(1 time)
NETs (1 time)
2012 Advances in the systemic treatment of neuroendocrine tumors in the era of molecular therapy.
21  pond reared rainbow trout
(1 time)
Cell Biology
(1 time)
CRRT (1 time)
MDA (1 time)
WRT (1 time)
2015 Some Antioxidants and Malondialdehyde Levels in the Flesh of Rainbow Trout, (Oncorhynchus mykiss W., 1792) from Various Feeding Habitats.
22  post-operative RRT following salvage surgery
(1 time)
Neoplasms
(1 time)
DRRT (1 time)
LRFS (1 time)
LRR (1 time)
2016 Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
23  potentially redundant repeat test
(1 time)
Medicine
(1 time)
ICU (1 time)
LFTs (1 time)
2021 Potentially redundant repeat liver function test ordering practices in australian hospitals: A 5-year multicentre retrospective observational study.
24  private rights
(1 time)
Psychiatry
(1 time)
INSE (1 time)
MRAI-R (1 time)
PAF (1 time)
2008 Psychometric properties of the Mental Retardation Attitude Inventory-Revised in Chinese college students.
25  pronounced for malignant indications
(1 time)
Nuclear Medicine
(1 time)
--- 2021 [Impact of COVID-19 on Nuclear Medicine Procedures in Germany 2020 - Results of a National Survey].
26  radiotherapy,peptide receptor radionuclide treatment
(1 time)
Gastroenterology
(1 time)
GEP-NEN (1 time)
MDT (1 time)
NEN (1 time)
2016 [Implementation of multidisciplinary team in the diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasm].